Chromosome and molecular abnormalities in myelodysplastic syndromes (Q34336409)

1 August 2017

1 reference

title

Chromosome and molecular abnormalities in myelodysplastic syndromes (English)

1 reference

1 August 2017

Fenaux P

1 reference

1 August 2017

publication date

1 June 2001

1 reference

International Journal of Hematology

1 August 2017

published in

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

429-437

1 reference

Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C-->T mutation and rapid fractional excretion of chlorzoxazone

1 August 2017

cites work

1 reference

12 December 2020

MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1.

1 reference

12 December 2020

Exposure to occupational and environmental factors in myelodysplastic syndromes. Preliminary results of a case-control study

1 reference

12 December 2020

Molecular genetics of myeloid leukemia: identification of the commonly deleted segment of chromosome 20

1 reference

12 December 2020

Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromes

1 reference

12 December 2020

Clinical and prognostic implications of chromosome 5q deletions: 96 high resolution studied patients.

1 reference

12 December 2020

A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells

1 reference

12 December 2020

Methylation of the p15(INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation

1 reference

12 December 2020

Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan.

1 reference

12 December 2020

The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator

1 reference

12 December 2020

Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations

1 reference

12 December 2020

Chromosomal deletions in the myelodysplastic syndrome

1 reference

12 December 2020

Detection of abnormal pretransplant clones in progenitor cells of patients who developed myelodysplasia after autologous transplantation.

1 reference

12 December 2020

p16 gene homozygous deletions in acute lymphoblastic leukemia

1 reference

12 December 2020

Comparison of spectral karyotyping and conventional cytogenetics in 39 patients with acute myeloid leukemia and myelodysplastic syndrome

1 reference

12 December 2020

Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome

1 reference

12 December 2020

Rare occurrence of mutations of the FLR exon of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)

1 reference

12 December 2020

From sideroblastic anemia to the role of mitochondrial DNA mutations in myelodysplastic syndromes

1 reference

12 December 2020

Myelodysplastic syndromes

1 reference

12 December 2020

Chromosome 8, occupational exposures, smoking, and acute nonlymphocytic leukemias: a population-based study

1 reference

12 December 2020

Chromosome abnormalities in the myelodysplastic syndromes.

1 reference

12 December 2020

Translocations and deletions of 5q13.1 in myelodysplasia and acute myelogenous leukemia: evidence for a novel critical locus.

1 reference

12 December 2020

FMS mutations in myelodysplastic, leukemic, and normal subjects

1 reference

12 December 2020

Mutations in the p53 gene in myelodysplastic syndromes

1 reference

12 December 2020

11p15 translocations involving the NUP98 gene in childhood therapy-related acute myeloid leukemia/myelodysplastic syndrome

1 reference

12 December 2020

Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression

1 reference

12 December 2020

FISH investigation of 5q and 7q deletions in MDS/AML reveals hidden translocations, insertions and fragmentations of the same chromosomes

1 reference

12 December 2020

Correlation of cytogenetic, molecular cytogenetic, and clinical findings in 59 patients with ANLL or MDS and abnormalities of the short arm of chromosome 12.

1 reference

12 December 2020

Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes

1 reference

12 December 2020

Human mortalin (HSPA9): a candidate for the myeloid leukemia tumor suppressor gene on 5q31

1 reference

12 December 2020

Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure

1 reference

12 December 2020

Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders

1 reference

12 December 2020

Telomere length in myelodysplastic syndromes

1 reference

12 December 2020

Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders

1 reference

12 December 2020

Combined immunophenotyping and in situ hybridization (FICTION): a rapid method to study cell lineage involvement in myelodysplastic syndromes

1 reference

12 December 2020

The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes

1 reference

12 December 2020

Cytogenetics of myelodysplastic syndromes

1 reference

12 December 2020

Elevated MLF1 expression correlates with malignant progression from myelodysplastic syndrome

1 reference

12 December 2020

Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2).

1 reference

12 December 2020

Cytogenetic studies in 69 patients with myelodysplastic syndromes (MDS)

1 reference

12 December 2020

Cytogenetic findings in primary and secondary MDS

1 reference

12 December 2020

1 reference

12 December 2020

Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

1 reference

12 December 2020

The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion

1 reference

12 December 2020

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

12 December 2020

Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1.

1 reference

12 December 2020

Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure

1 reference

12 December 2020

The benzene metabolite, hydroquinone, selectively induces 5q31- and -7 in human CD34+CD19- bone marrow cells

1 reference

12 December 2020

Molecular cytogenetic delineation of the critical deleted region in the 5q- syndrome

1 reference

12 December 2020

Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes

1 reference

12 December 2020

Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Español de Citogenética Hematológica

1 reference

12 December 2020

Chromosome abnormalities in myelodysplastic syndromes

1 reference

12 December 2020

Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements

1 reference

12 December 2020

17p Deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ

1 reference

12 December 2020

Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion

1 reference

12 December 2020

Isolated isochromosome 17q: a distinct type of mixed myeloproliferative disorder/myelodysplastic syndrome with an aggressive clinical course

1 reference

12 December 2020

Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia

1 reference

12 December 2020

Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases

1 reference

12 December 2020

Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis

1 reference

12 December 2020

Evidence for two molecular steps in the pathogenesis of myeloid disorders associated with deletion of chromosome 7 long arm

1 reference

12 December 2020

Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval

1 reference

12 December 2020

Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia

1 reference

12 December 2020

Fluorescence in situ hybridization: a sensitive method for trisomy 8 detection in bone marrow specimens

1 reference

12 December 2020

International scoring system for evaluating prognosis in myelodysplastic syndromes

1 reference

12 December 2020

Inactivation of the retinoblastoma gene appears to be very uncommon in myelodysplastic syndromes

1 reference

12 December 2020

Transcription mapping of the 5q- syndrome critical region: cloning of two novel genes and sequencing, expression, and mapping of a further six novel cDNAs

1 reference

12 December 2020

Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centro

1 reference

12 December 2020

The benzene metabolites hydroquinone and catechol act in synergy to induce dose-dependent hypoploidy and -5q31 in a human cell line

1 reference

12 December 2020

Glutathione S transferase theta 1 gene defects in myelodysplastic syndromes and their correlation with karyotype and exposure to potential carcinogens.

1 reference

12 December 2020

Chromosome study of 85 patients with myelodysplastic syndrome

1 reference

12 December 2020

The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1.

1 reference

12 December 2020

Cytogenetics of myelodysplasia and acute myeloid leukaemia in aircrew and people treated with radiotherapy

1 reference

12 December 2020

p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies

1 reference

12 December 2020

Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia

1 reference

12 December 2020

N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome

1 reference

12 December 2020

AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02994004

1 reference

Dimensions Publication ID

1 August 2017

1012493520

0 references

1 reference